Brain hypometabolism in patients with mesial-temporal sclerosis demonstrated by FDG-PET;Hipometabolismo cerebral em pacientes com esclerose mesial temporal demonstrado pelo FDG-PET

Arquivos de Neuro-Psiquiatria

Volumn 58, Issue 3 B, 2000, Pages 869-876

  Duarte, Paulo Schiavom ^a   Zhuang, Hongming ^b   King, David ^c   Alavi, Abass ^a  

^a Fleury   (Brazil)

^b Hospital da Universidade da Pensilvânia Filadélfia   (United States)

^c CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

Author keywords

Epilepsy; FDG; Mesial temporal sclerosis; PET

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; ARTICLE; BRAIN DISEASE; BRAIN HYPOMETABOLISM; BRAIN METABOLISM; BRAIN REGION; CLINICAL ARTICLE; COMPLEX PARTIAL SEIZURE; ELECTROENCEPHALOGRAM; EPILEPTIC FOCUS; FEMALE; FRONTAL LOBE; HIPPOCAMPAL SCLEROSIS; HUMAN; MALE; POSITRON EMISSION TOMOGRAPHY; TEMPORAL LOBE;

EID: 0033813671     PISSN: 0004282X     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0004-282x2000000500012     Document Type: Article

References (30)

1. Pathological findings underlying local temporal lobe hypometabolism in partial epilepsy
2. The use and impact of positron computed tomography scanning in epilepsy
3. Differences between lateral and mesial temporal metabolism interictally in epilepsy of mesial temporal origin
4. Consequences of severe epilepsy: Neuropathological aspects
5. Hippocampal neuron loss in temporal lobe epilepsy: Correlation with early childhood convulsions
6. Epilepsy and neuron loss in the hippocampus
7. The significance of mesial temporal sclerosis (Ammon's horn sclerosis) in epilepsy
8. Mesial temporal sclerosis: Pathogenesis, diagnosis, and management
9. Hippocampal resections and the use of human tissue in defining temporal lobe epilepsy syndromes
10. Entorhinal-hippocampal interactions in medial temporal lobe epilepsy
11. Seizure characteristics, pathology, and outcome after temporal lobectomy
12. Surgical treatment of drug-resistant epilepsy due to mesial temporal sclerosis: Etiology and significance
13. Positron emission tomography studies of cerebral glucose metabolism in chronic partial epilepsy
14. Interictal metabolic anatomy of mesial temporal lobe epilepsy
15. Hippocampal neuronal loss and regional hypometabolism in temporal lobe epilepsy
16. Topography of interictal glucose hypometabolism in unilateral mesiotemporal epilepsy
17. Quantifying interictal metabolic activity in human temporal lobe epilepsy
18. Prefrontal asymmetric interictal glucose hypometabolism and cognitive impairment in patients with temporal lobe epilepsy
19. Thalamic glucose metabolism in temporal lobe epilepsy measured with 18f-fdg positron emission tomography (PET)
20. Subcortical metabolic alterations in partial epilepsy
21. Standards for performance measurements of pet scanners: Evaluation with the UGM PENN-PET 240H Scanner
22. Three-dimensional imaging characteristics of the HEAD PENN-PET Scanner
23. Comparison of anatomically-defined versus physiologically-based regional localization: Effects on PET-FDG quantitation
24. Hippocampal atrophy is not a major determinant of regional hypometabolism in temporal lobe epilepsy
25. Epilepsy and the temporal lobes: A clinical, electroencephalographic and neuropathological study of the brain in epilepsy, with particular reference to the temporal lobes
26. Effect of phenytoin on human cerebral glucose metabolism
27. Barbiturates reduce human cerebral glucose metabolism
28. Antiepileptic drugs and cerebral glucose metabolism
29. The effect of carbamazepine on cerebral glucose metabolism
30. Pattern of interictal hypometabolism in pet scans with fludeoxyglucose f 18 reflects prior seizure types in patients with mesial temporal lobe seizures